Leptospira Canicola L-15 Strain C-51; Leptospira Grippotyphosa 1550 Lot 10005 St
616 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
616
Total Reports
77
Deaths Reported
1250.0%
Death Rate
Active Ingredients
Leptospira Canicola L-15 Strain C-51; Leptospira Grippotyphosa 1550 Lot 10005 St
Administration Routes
SubcutaneousUnknown
Species Affected
Dog 615
Cattle 1
Most Affected Breeds
Retriever - Labrador 59
Terrier - Bull - American Pit 43
Chihuahua 28
Boxer (German Boxer) 26
Retriever - Golden 25
Terrier - Yorkshire 24
Beagle 20
Shih Tzu 20
Maltese 18
Dachshund (unspecified) 17
Most Reported Reactions
Vomiting 222
Lethargy (see also Central nervous system depression in 'Neurological') 165
Facial swelling (see also 'Skin') 104
Anorexia 86
Anaphylactoid reaction 77
Other abnormal test result NOS 75
Diarrhoea 70
Pale mucous membrane 55
Hives (see also 'Skin') 55
Urticaria 54
Fever 52
Elevated alanine aminotransferase (ALT) 52
Outcome Breakdown
Ongoing
283 (45.9%)
Recovered/Normal
233 (37.8%)
Euthanized
40 (6.5%)
Died
37 (6.0%)
Outcome Unknown
23 (3.7%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.